Ligand validation:2EWN

BTX: ((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXY-TETRAHYDROFURAN-2-YL)METHYL 5-((3AS,4S,6AR)-2-OXO-HEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL)PENTYL HYDROGEN PHOSPHATE

BTX is a Ligand Of Interest in 2EWN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2EWN_BTX_A_501	71%	13%	0.143	0.965	1.95	2.03	8	12	8	0	100%	1
2EWN_BTX_B_500	55%	9%	0.165	0.934	2.08	2.41	11	15	4	0	100%	1
4WF2_BTX_A_501	75%	2%	0.123	0.957	4.07	2.73	13	11	0	0	100%	1
2E41_BTX_A_1301	91%	11%	0.078	0.965	2.17	2.05	12	12	0	0	100%	1
4DQ2_BTX_A_500	31%	4%	0.277	0.95	2.18	3.65	7	23	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.